Biglycan regulates the expression of EGF receptors through EGF signaling pathways in human articular chondrocytes

Connective Tissue Research

Volumn 51, Issue 5, 2010, Pages 347-358

  Iacob, Stanca ^a   Cs Szabo, Gabriella ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Akt; Biglycan; Chondrocytes; Epidermal growth factor; Epidermal growth factor receptor; Extracellular signal regulated MAP kinases

Indexed keywords

BIGLYCAN; EPIDERMAL GROWTH FACTOR RECEPTOR; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE B;

ADOLESCENT; ADULT; AGED; ARTICLE; CARTILAGE CELL; CELL CULTURE; CELL ISOLATION; CELL SURFACE; CHILD; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRACELLULAR SIGNALING; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; REGULATORY MECHANISM; SCHOOL CHILD; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; BIGLYCAN; CARTILAGE, ARTICULAR; CELLS, CULTURED; CHONDROCYTES; EPIDERMAL GROWTH FACTOR; FEMALE; GENE EXPRESSION REGULATION; HOMEOSTASIS; HUMANS; MALE; MIDDLE AGED; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION; YOUNG ADULT;

EID: 77956575554     PISSN: 03008207     EISSN: 16078438     Source Type: Journal    
DOI: 10.3109/03008200903427695     Document Type: Article

References (40)

1. Iozzo, R.V. (1998). Matrix proteoglycans: From molecular design to cellular function. Ann. Rev. Biochem. 67:609-652.
2. Iozzo, R.V. (1999). The biology of the small leucine-rich proteoglycans. Functional network of interactive proteins. J. Biol. Chem. 274:18843-18846.
3. Roughley, P.J. (2006). The structure and function of cartilage proteoglycans. Eur. Cells Mat. 12:92-101.
4. Wiberg, C., Klatt, A.R., Wagener, R., Paulsson, M., Bateman, J.F., Heinegard, D., and Morgelin, M. (2003). Complexes of matrilin-1 and biglycan or decorin connect collagen VI microfibrils to both collagen II and aggrecan. J. Biol. Chem. 278:37698-37704.
5. Young, M.F., Bi, Y., Ameye, L., and Chen, X.-D. (2002). Biglycan knockout mice: New models for musculoskeletal diseases. Glycoconjugate J. 19:257-262.
6. Ameye, L.G., Deberg, M., Oliveira, M., Labasse, A., Aeschlimann, J.M., and Henrotin, Y. (2007). The chemical biomarkers C2C, Coll2-1, and Coll2-1NO2 provide complementary information on type II collagen catabolism in healthy and osteoarthritic mice. Arthritis Rheum. 56:3336-3346.
7. Ameye, L., and Young, M.F. (2002). Mice deficient in small leucine-rich proteoglycans: Novel in vivo models for osteoporosis, osteoarthritis, Ehlers-Danlos syndrome, muscular dystrophy, and corneal diseases. Glycobiology 12:107R-116R.
8. Corsi, A., Xu, T., Chen, X.D., Boyde, A., Liang, J., Mankani, M., Sommer, B., Iozzo, R.V., Eichstetter, I., Robey, P.G., Bianco, P., and Young, M.F. (2002). Phenotypic effects of biglycan deficiency are linked to collagen fibril abnormalities, are synergized by decorin deficiency, and mimic Ehlers-Danlos-like changes in bone and other connective tissues. J. Bone Min. Res. 17:1180-1189.
9. Le Graverand, M.P., Eggerer, J., Vignon, E., Otterness, I.G., Barclay, L., and Hart, D.A. (2002). Assessment of specific mRNA levels in cartilage regions in a lapine model of osteoarthritis. J. Orthop. Res. 20:535-544.
10. Liu, W., Burton-Wurster, N., Glant, T.T., Tashman, S., Sumner, R.D., Kamath, R., Lust, G., Kimura, J., and Cs-Szabo, G. (2003). Spontaneous and experimental osteoarthritis in dog: Similarities and differences in proteoglycan levels. J. Orthop. Res. 21:730-737.
11. Cs-Szabo, G., Ragasa, D., Berger, R.A., and Kuettner, K.E. (2002). Small proteoglycans in knee and ankle cartilage. In Many Faces of Osteoarthritis, V. Hascall and K.E. Kuettner (eds.) pp. 369-372. Basel, Switzerland: Birkhauser Verlag AG.
12. Poole, A.R., Rosenberg, L.C., Reiner, A., Ionescu, M., Bogoch, E., and Roughley, P.J. (1990). Contents and distributions of the proteoglycans decorin and biglycan in normal and osteoarthritic human articular cartilage. J. Orthop. Res. 14:681-689.
13. Cs-Szabo, G., Melching, L.I., Roughley, P.J., and Glant, T.T. (1997). Changes in messenger RNA and protein levels of proteoglycans and link protein in human osteoarthritic cartilage samples. Arthritis Rheum. 40:1037-1045.
14. Ribault, D., Khatib, A.-M., Panasyuk, A., Barbara, A., Bouizar, Z., and Mitrovic, R.D. (1997). Mitogeninc and metabolic actions of epidermal growth factor on rat articular chondrocytes: Modulation by fetal calf serum, transforming growth factor-b, and tyrphostin. Arch. Biochem. Biophys. 337:149-158.
15. Schmal, H., Mehlhorn, A.T., Zwingmann, J., Muller, C.A., Stark, G.B., and Sudkamp, N.P. (2005). Stimulation of chondrocytes in vitro by gene transfer with plasmids coding for epidermal growth factor (hEGF) and basic fibroblast growth factor (bFGF). Cytotherapy 7:292-300.
16. Marshall, C.J. (1995). Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signalregulated kinase activation. Cell 80:179-185.
17. Santos, S.D.M., Verveer, P.J., and Bastiaens, P.I.H. (2007). Growth factor-induced MAPK network topology shapes Erk response determining PC-12 cell fate. Nat. Cell Biol. 9:324-330, S1-S6.
18. Green, L.A., and Tischler, A.S. (1976). Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc. Natl. Acad. Sci. USA 73:2424-2428.
19. Liang, Y., Haring, M., Roughley, P.J., Margolis, R.K., and Margolis, R.U. (1997). Glypican and biglycan in the nuclei of neurons and glioma cells: Presence of functional nuclear localization signals and dynamic changes in glypican during the cell cycle. J. Cell. Biol. 139:851-864.
20. Moscatello, D.K., Santra, M., Mann, D.M., McQuillan, D.J., Wong, A.J., and Iozzo, R.V. (1998). Decorin suppresses tumor cell growth by activating the epidermal growth factor receptor. J. Clin. Invest. 101:406-412.
21. Kresse, H., and Schonherr, E. (2001). Proteoglycans of the extracellular matrix and growth control. J. Cell. Physiol. 189:266-274.
22. Cs-Szabo, G. (2007). Small leucine-rich proteoglycans of the cartilage and their potential role in tissue repair. Osteoarthr. Cartil. 15(Suppl. 2):B30.
23. Shiraha, H., Gupta, K., Drabik, K., and Wells, A. (2000). Aging fibroblasts present reduced epidermal growth factor (EGF) responsiveness due to preferential loss of EGF receptors. J. Biol. Chem. 275:19343-19351.
24. Kinoshita, A., Takigawa, M., and Suzuki, F. (1992). Demonstration of receptors for epidermal growth factor on cultured rabbit chondrocytes and regulation of their expression by various growth and differentiation factors. Biochem. Biophys. Res. Comm. 183:14-20.
25. Farahat, M.N., Yanni, G., Poston, R., and Panayi, G.S. (1993). Cytokine expression in synovial membranes of patients with rheumatoid arthritis and osteoarthritis. Ann. Rheum. Dis. 52:870-875.
26. Collins, D.H. (1949). Osteoarthritis [Chapter V]. In The Pathology of Articular and Spinal Diseases. London, UK: E. Arnold and Co., 74-115.
27. Muehleman, C., Bareither, D., Huch, K., Cole, A.A., and Kuettner, K.E. (1997). Prevalence of degenerative morphological changes in the joints of the lower extremity. Osteoarthr. Cartil. 5:23-37.
28. Kuettner, K.E., Pauli, B.D., Gal, G., Memoli, V.A., and Schenk, R.K. (1982) Synthesis of cartilage matrix by mammalian chondrocytes in vitro. I. Isolation, culture characteristics, and morphology. J. Cell. Biol. 93:743-750.
29. Pfaffl, M.W. (2001). A new mathematical model for relative quantification in real-time RT-PCR. Nucl. Acids Res. 29:e45.
30. Gotte, M., Sofeu Feugaing, D.D., and Kresse, H. (2004). Biglycan is internalized via a chlorpromazine-sensitive route. Cell. Mol. Biol. Lett. 9:475-481.
31. Goldring, M.B., and Goldring, S. (2007). Osteoarthritis. [Review]. J. Cell. Physiol. 213:626-634.
32. Goldring, M.B. (2000). The role of the chondrocyte in osteoarthritis. [Review]. Arthritis Rheum. 43:1916-1926.
33. Klooster, A.R., and Bernier, S.M. (2005). Tumor necrosis factor alpha and epidermal growth factor act additively to inhibit matrix gene expression by chondrocytes. Arthritis Res. Ther. 7:R127-R138.
34. Bi, Y., Nielsen, K.L., Kilts, T.M., Yoon, A., Karsdal, M., Wimer, H.F., Greenfield, E.M., Heegaard, A.M., and Young, M.F. (2006). Biglycan deficiency increases osteoclast differentiation and activity due to defective osteoblasts. Bone 38:778-786.
35. Woodard, J.C., Donovan, G.A., and Fisher, L.W. (1997). Pathogenesis of vitamin (A and D)-induced premature growth-plate closure in calves. Bone 21:171-182.
36. Hayashi, Y., Liu, C.-Y., Jester, J.J., Hayashi, M., Wang, I.-J., Funderburgh, J.L., Saika, S., Roughley, P.J., Kao, C.W.-C., and Kao, W.W.-Y. (2005). Excess biglycan causes eyelid malformation by perturbing muscle development and TGF-alpha signaling. Dev. Biol. 277:222-234.
37. Mio, K., Kirkham, J., and Bonass, W.A. (2007). Possible role of extracellular signal-regulated kinase pathway in regulation of Sox9 mRNA expression in chondrocytes under hydrostatic pressure. J. Biosci. Bioeng. 104:506-509.
38. Fanning, P.J., Emkey, G., Smith, R.J., Grodzinsky, A.J., Szasz, N., and Trippel, S.B. (2003). Mechanical regulation of mitogen-activated protein kinase signaling in articular chondoryctes. J. Biol. Chem. 278:50940-50948.
39. Zimmermann, S., and Moelling, K. (1999). Phosphorylation and regulation of Raf by Akt. Science 286:1741-1744.
40. Kajanne, R., Miettinen, P., Mehlem, A., Leivonen, S.-K., Birrer, M., Foschi, M., Kahari, V.-M., and Leppa, S. (2007). EGF-R regulates MMP function in fibroblasts through MAPK and AP-1 pathways. J. Cell. Physiol. 212:489-497.